Abstract
Introduction
Thousands of people all over t he world are considered legally blind or have very poor vision due t o kerat oconus, high or irregular ast igmat ism and ot her forms of corneal irregularit ies or dyst rophies.
The concept of opt ically neut ralizing t he cornea wit h a lens which enclosed a liquid reservoir over t he corneal front surface was proposed in 1508 by Leonardo da Vinci. 1 Almost 400 years lat er Fick 2 designed t he earliest pract ical cont act lenses, which were scleral lenses. His idea was t o neut ralize t he opt ical effect s of t he corneal dist ort ion for pat ient s wit h irregular ast igmat ism by using afocal scleral glass shells.
Modern scleral lenses are indicat ed for several ocular condit ions such as kerat oconus and ot her primary corneal ect asia, post corneal t ransplant when residual high refract ive error exist s or t he surface remains highly irregular, serious dry eye condit ions and neurot rophic kerat it is, and can nearly always be t t ed successfully. [3] [4] [5] These lenses offer t wo unique advant ages.
First ly, t hey are support ed by t he sclera and t herefore can be t t ed on eyes wit h markedly irregular corneas. This is part icularly import ant for pat ient s wit h corneal irregularit y, when vision cannot be improved wit h rigid corneal cont act lenses, eit her because of t he pat ient s' poor t olerance level or inabilit y t o t such a lens.
Secondly, t here is t he const ant aqueous reservoir bet ween t he lens and t he cornea. This reservoir neut ralizes most of t he irregular ast igmat ism and prot ect s t he corneal surface from t he desiccat ing effect s of exposure t o air and t he frict ion of blinking. This is especially import ant in cases of non-healing corneal epit helial defect s and ot her ocular surface diseases t hat cannot be resolved wit h ot her current ly available t herapeut ic modalit ies.
Unt il t he last decade of t he past cent ury, t hese advant ages could not be fully realized because of chronic corneal hypoxia at t ribut ed t o low gaseous permeabilit y of polymet hyl met hacrylat e (PMMA) and ot her mat erials from which t he lenses were made. [6] [7] [8] The development of rigid gas-permeable plast ics great ly reduced t he hypoxic complicat ions associat ed wit h daily wear of corneal lenses and added a new dimension t o t he pot ent ial of scleral lenses for t he visual rehabilit at ion of pat ient s wit h markedly irregular corneas and t reat ment of ocular surface disorders. In 1983 Ezekiel 9 described t he use of preformed, fenest rat ed, silicone/ acrylat e gas permeable scleral cont act lenses in t t ing pat ient s wit h kerat oconus, severe myopia, aphakia, and corneal scarring. Since t hen, new t echniques in t he manufact ure of rigid gas-permeable scleral lenses have been developed. [10] [11] [12] In t his art icle, we will report our experience in fit t ing pat ient s wit h sealed non-fenest rat ed GP-SCL and assess t he vision rehabilit at ion and t herapeut ic benefit s in t he management of various corneal and ocular surface diseases.
Methods
Clinical dat a from t he records of 97 consecut ive pat ient s (140 eyes), t t ed wit h GP-SCL bet ween January 2003 and December 2008, were ret rospect ively analyzed t o det ermine t he indicat ions for lens t t ing and visual out comes.
Pat ient s were referred t o t he cont act lens clinic in Hadassah Universit y Hospit al, due t o severe corneal irregularit ies or corneal surface disorders resist ant t o ot her t herapeut ic opt ions. Pat ient s referred for vision rehabilit at ion were unable t o wear corneal rigid gas permeable (RGP) lenses or t t ing of such lenses was cont raindicat ed. Ocular pat hologies included: kerat oconus, kerat oglobus and pellucid marginal degenerat ion (KC), corneal irregularit y aft er penet rat ing kerat oplast y (PKP), severe exposure kerat opat hy, St evens-Johnson syndrome (SJS), graft versus host disease (GVHD) or ot her ocular surface disorders (OSD), corneal ect asia aft er refract ive surgery and high refract ive errors (HRE). Use of hyper-Dk/ t RGP lens mat erials (> 100 Dk/ t ) have been shown t o supply enough oxygen t o t he cornea in all day lens wearers, which does not compromise corneal healt h in t erms of increased corneal swelling. 13 Each sleral lens was preformed, non-fenest rat ed and sealed, wit h an overall diamet er of 18.5 mm, designed t o barely clear t he highest point of t he cornea and t o provide t he most uniform t hickness pro le of t he uid accumulat ed bet ween t he lens and t he cornea. By maint aining t he minimal t hickness of t his reservoir, we opt imized t he oxygen t ransmissibilit y of t he lens-cornea syst em and minimized t he degradat ion of vision t hat occurs if excessive t ear debris accumulat e inside t his reservoir during lens wear. The t hickness of t his pro le ranged bet ween one t hird of corneal t hickness and 300-400 mm. The curvat ure of t he cent ral back surface of each lens (opt ic zone) was chosen t o maint ain a shallow, but de nit e clearance of t he cornea and limbus, t hus t he lens was ent irely support ed by t he sclera. Corneal clearance was evaluat ed by slit lamp examinat ion t o est ablish t he opt imal sagit t al height of each lens.
GP-SCL features
In an average lens, t he int ernal opt ic zone of 12.5 mm was a single curve surrounded by a 1.5-2.0 mm wide t ransit ional zone vault ing t he limbus and merging seamlessly int o t he post erior hapt ic surface ( Figure 1 ). The hapt ic paramet ers of individual lenses were det ermined by observing t he vascular compression pat t erns of t he bulbar conj unct iva, using a series of diagnost ic lenses of different hapt ic designs aimed at minimizing lens induced compression of conj unct ival blood vessels and enabling unobst ruct ed blood circulat ion. The average cent er t hickness of t he lenses was 0.35 mm.
Fluorescein uid-venting test
Aft er t he lens had been placed on t he eye wit h st erile saline and had been in posit ion for at least 2 hours, uorescein dye was inst alled. Aft er 5 minut es, a slit lamp examinat ion wit h cobalt blue lt er or opt ic sect ion was performed. 4, 5, 14 In cases when uorescein diffused under t he lens hapt ic and reached t he pre-corneal liquid chamber independent ly or by gent le palpat ion, t he t est was considered posit ive ( Figure 2 ) if no uorescence was seen -t he t est was considered negat ive.
Indications for success/ failure
We considered t he t t ing of GP-SCL t o be successful when wearing t ime of 10 hours a day or more, wit h no lens adhesion on removal, was reached. Part ial success was de ned as abilit y t o wear t he lenses bet ween 6 t o 10 hours a day. Wearing of GP-SCL less t hen 6 hours a day was considered t o be a failure.
Results
A t ot al of 97 pat ient s (140 eyes) included 29 females (30 %) and 68 males (70 %), t he pat ient s' ages ranged bet ween 16-77 years. Mean follow up was 27.5 mont hs (range 1-71).
Indications
The primary clinical indicat ions for GP-SCL could be cat egorized in t hree main cat egories: vision improvement (134 eyes), management of severe ocular surface disease and corneal prot ect ion (6 eyes), and mult iple indicat ions t hat include bot h vision improvement and corneal prot ect ion (10 eyes).
The most common diagnoses for use of GP-SCL was kerat oconus (KC) -88 eyes (63 %), followed by ext reme corneal irregularit ies or high ast igmat ism aft er penet rat ing kerat oplast y (PKP) -39 eyes (28 %). Ot her indicat ions included various ocular surface disorders (OSD) -6 eyes (4 %): 2 eyes wit h corneal st em cell disorder (St even-Johnson syndrome), 2 eyes wit h severe dry eye syndrome due t o GVHD, 1 eye was t reat ed for severe exposure kerat opat hy and 1 eye had post herpet ic kerat it is.
Four eyes (3 %) were t t ed wit h GP-SCL for post refract ive surgery kerat oect asia (2 eyes PRK, 2 eyes LASIK); 3 eyes (2 %) fit t ed due t o high refract ive errors: 2 eyes were aphakic and 1 eye had high myopia wit h spherical equivalent of -16.00 diopt er.
Ef cacy
Eight y eight of t he 134 eyes t hat were t t ed primarily t o improve vision had kerat oconus. Anot her 39 eyes were t t ed due t o inadequat e spect acle-correct ed vision aft er successful penet rat ing kerat oplast y. Some of t hose eyes had undergone mult iple unsuccessful surgical procedures for reducing t he iat rogenic ast igmat ism. In most of t hese cases, t he scleral lens provided useful correct ed vision, regardless of t he amount or t ype of corneal ast igmat ism present .
Median visual acuit y (VA) wit h GP-SCL was 20/ 32 (Snellen fract ion) and ranged from 20/ 400 t o 20/ 20. The median best spect acle correct ed VA wit hout a cont act lens was 20/ 70 (range 20/ 800-20/ 30). There was a signi cant increase in VA wit h scleral lenses compared t o t he best spect acle correct ed VA ( P < 0.001, signed rank t est ).
Improvement in best -correct ed visual acuit y (BCVA), de ned as a gain of t wo or more decimal acuit y lines, was observed in 125 eyes (93 %) out of t he 134 eyes t reat ed for vision improvement .
Visual out comes varied according t o t he preexist ing ocular st at us. The best visual result s were obt ained in t he post PKP group, which achieved 20/ 40 or more in 92 % of cases wit h median BCVA of 20/ 25. Eyes in t he kerat oconus group achieved 20/ 40 or more in 84 % of cases wit h median BCVA of 20/ 32. In ot her groups, median BCVA was as follows: OSD 20/ 50, kerat oect asia 20/ 30, HRE 20/ 32 (Table 1) .
During t he period of st udy 102 eyes (73 %) were successfully t t ed, as de ned by success crit eria, i.e. able t o wear t he lenses for more t han 10 hours a day, and 15 eyes (11 %) achieved part ial success wit h GP-SCL. Mean wearing t ime of successful wearers was 12.2 hours a day (range 10-16). The mean wearing t ime among all t t ed pat ient s was 11 hours a day (ranged 5-16). Wearing t imes of t he t reat ed groups are shown in Figure 3 .
Sevent y eight eyes (77 %) in t he successful wearers group had posit ive uorescein dye t est (Table 2) . Fluorescein dye penet rat ion under t he lens hapt ic, i.e. posit ive uid-vent ing was highly associat ed wit h successful GP-SCL wearing, (P = 0.0007, chi-square t est ) Twent y pat ient s (21 %) failed t o wear GP-SCL. Mean wearing t ime in t his group was 5.8 hours a day (range 3-8) 
Tabl e 1 Best visual acuit y and average wearing t ime achieved wit h GP-SCL t t ed for various condit ions and range

Discussion
This ret rospect ive review shows t hat medical applicat ions of GP-SCL include bot h visual and t herapeut ic uses for a range of complicat ed corneal and ocular surface condit ions for which t reat ment by ot her met hods is eit her unsuit able or less effect ive. Diagnoses may be cat egorized int o four main groups: primary or induced kerat oect asia, post penet rat ing kerat oplast y, ocular surface diseases and high refract ive errors. In t he current st udy, pat ient s wit h kerat oconus and ot her forms of irregular corneal surface formed t he largest group (63 %), followed by post penet rat ing kerat oplast y iat rogenic ast igmat ism group (28 %), and ocular surface disorders group (4 %).
Vision improvement was t he primary indicat ion for GP-SCL in nearly 95 % of t he t t ed eyes, and was achieved in most inst ances by neut ralizing t he corneal irregularit ies or correct ing exist ing refract ive errors.
Visual out comes varied according t o t he preexist ing ocular st at us. The best visual result s were obt ained in t he post kerat oplast y group, which achieved 20/ 40 or bet t er in 92 % of cases. These pat ient s were t t ed wit h GP-SCL t o correct post PKP corneal ast igmat ism or corneal irregularit ies, induced by t ransplant misalignment .
The pat ient s suffering from kerat oconus had severe forms of t he disease leading t o failure wit h corneal cont act lenses or were unable t o t olerat e wearing t his t ype of lenses. They were t t ed wit h GP-SCL as t he last alt ernat ive before surgery. Visual out comes obt ained in t his group showed signi cant improvement of visual acuit y, 20/ 40 or bet t er in 84 % of pat ient s.
Kerat oconus pat ient s are commonly adolescent s, and may require corneal surgery during t heir lifet ime. The risks associat ed wit h t he kerat oplast y procedure, which include infect ion, rej ect ion, and severe ast igmat ism, may be great er t han t hose at t ribut ed t o GP-SCL wear.
15
Comparison with previous studies
Various evaluat ion met hods of GP-SCL performance demonst rat e different result s, t hus it is dif cult t o make direct comparisons bet ween st udies. Since t he first successful applicat ion of gas-permeable scleral lenses by Ezekiel 9 in 1983, several st udies have been published. The st udy designs varied in size, diagnoses, t t ing met hods, scleral lens t ypes and mat erials. However, as in our st udy t he most common indicat ion was kerat oconus, followed by post kerat oplast y. 5, [16] [17] [18] The large ret rospect ive st udies of Pullum and Buckley 16 and Rosent hal and Crot eau 4 on 530 and 538 pat ient s, respect ively, included a host of clinical indicat ions but kerat oconus and post penet rat ing kerat oplast y st ill comprised t he t wo largest groups. However in a st udy carried out in t he early ninet ies, Tan et al. 19, 20 report ed kerat oconus as t he most common condit ion requiring scleral lenses followed by aphakia and t hen post kerat oplast y. Lenses used varied great ly in size from 15 mm t o 23mm. 4, 5, 18, 21 Schornack and Pat el 21 used a scleral lenses wit h an overall diamet er of 18.2 mm, which is similar t o t he lenses used in our st udy (18.5 mm). They suggest ed t hat lenses t hat are support ed by t he sclera and clear bot h t he cornea and limbus could be defined as ' scleral' lenses irrespect ive of t he act ual overall diamet er.
The charact erist ics of our pat ient s and our result s were similar t o t hose report ed by ot her st udies 5, 18 regarding visual rehabilit at ion. Our st udy con rmed t he best acuit y result s achieved in pat ient s wit h irregular or severe ast igmat ic t opography. 5, [16] [17] [18] 20 St udies t hat included indicat ions ot her t han visual correct ion, t reat ment of ocular surface disease for example, showed less marked improvement in VA. The reason of lower visual result s is primarily t herapeut ic indicat ion for scleral lens fit t ing i.e. corneal prot ect ion, t ear conservat ion, or pain relief.
Success rate
Development of scleral lenses wit h a smoot her cont inuous back surface t hat follows more precisely t he underlying scleral surface has made prolonged, comfort able scleral lens wear possible. Penet rat ion of liquids under t he lens in sit u, i.e. posit ive uid-vent ing was found t o be associat ed wit h successful t and increased wearing t ime.
Moreover, t he combinat ion of high oxygen permeabilit y and favorable t ear exchange allowed by t he lens back geomet ry may diminish t he incidence of complicat ions such as corneal edema or lens adhesion.
Failure rat es during t he period of our st udy were 21 %. This number concurs wit h t he result s of ot her invest igat ions. In a ret rospect ive st udy, Tan et al. 20 found t hat 71 % of t he eyes could cont inue wearing t he scleral lens, Pullum and Buckley 16 described t hat 22 % of t heir cases failed a scleral t rial or st opped wearing t heir scleral lenses complet ely. Failure rat e of 10.4 % was report ed by Segal et al.
,5 while Schornack and Pat el 21 report ed t hat 12 out of 32 pat ient s (38 %) decided not t o pursue scleral lens wear aft er init ial evaluat ion.
In conclusion, modern scleral cont act lenses can be used successfully for visual rehabilit at ion and management of a wide range of corneal disorders t hat have not responded adequat ely t o ot her t reat ment s. The main indicat ion for GP-SCL is opt ical correct ion of an irregular corneal surface, especially due t o kerat oconus and post corneal t ransplant . In t he kerat oconus group, GP-SCL serves as an alt ernat ive t o surgery. In t he post -PKP group GP-SCL provided an alt ernat ive t o refract ive surgery or repeat ed corneal t ransplant at ion. Scleral lenses were found beneficial in several forms of ocular surface diseases. Therapeut ic benefit s of GP-SCL enhance t he management of ocular surface diseases when medical t reat ment s have failed and surgery is undesirable.
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